Ozempic is cheaper than Wegovy. At list price, a month of Ozempic costs around $936 compared to $1,349 for Wegovy, a difference of roughly $400 per month. But the price you actually pay depends heavily on your insurance, your diagnosis, and which drug your plan will cover at all.
List Price Comparison
Both Ozempic and Wegovy are made by Novo Nordisk and contain the same active ingredient, semaglutide. The price gap comes down to dosage and intended use. Ozempic is approved for type 2 diabetes at doses up to 2 mg per week, while Wegovy is approved for weight management at a maintenance dose of 2.4 mg per week (with a maximum of 7.2 mg). A higher dose means more drug per pen, which partly explains why Wegovy carries a higher price tag.
Without insurance, you can expect to pay $900 to $1,000 per month for Ozempic and $1,300 to $1,400 per month for Wegovy. These figures reflect the manufacturer’s list price, not what most people actually pay out of pocket after insurance or discount programs.
Why Insurance Changes the Math
The sticker price difference matters far less than whether your insurance covers the drug at all. And here’s where things get complicated: most insurance companies cover Ozempic only for a type 2 diabetes diagnosis, and many plans don’t cover Wegovy for weight loss. If your plan covers one but not the other, the “cheaper” drug is whichever one your insurer will pay for.
Ozempic generally has broader insurance coverage because diabetes medications have been standard on formularies for years. Wegovy coverage is much spottier. Many employers simply don’t include weight management drugs in their plans, leaving patients to pay the full cost themselves. If your insurer covers Ozempic with a typical copay, you might pay $25 to $100 per month. If you’re paying cash for Wegovy, you’re looking at over $1,300.
Medicare follows the same pattern. Part D plans can cover Ozempic and other GLP-1 drugs approved for type 2 diabetes. But drugs prescribed solely for weight loss, including Wegovy, are generally excluded from Part D coverage. Medicare beneficiaries may only access Wegovy if they have a qualifying condition like type 2 diabetes or cardiovascular disease.
Savings Programs From Novo Nordisk
Novo Nordisk offers savings cards for both medications that reduce your copay to as little as $25 per month, with a maximum savings of $100 per month. The Ozempic card applies for up to three months. The Wegovy card can be used each time you fill a valid prescription while the program remains available. Both require commercial insurance and exclude government insurance beneficiaries, so people on Medicare or Medicaid can’t use them.
These cards help if your insurance already covers the drug but sticks you with a high copay. They won’t help much if your plan doesn’t cover the medication at all, since $100 off a $1,349 bill still leaves you with $1,249.
Why Some People Use Ozempic for Weight Loss
Because Ozempic is cheaper and more widely covered, some doctors prescribe it off-label for weight loss. This is legal and common, but it creates its own headaches. Insurance companies that cover Ozempic for diabetes may deny claims if the prescription is written for weight management. You could end up paying the full uninsured price anyway.
There’s also a dosing consideration. Ozempic maxes out at 2 mg per week, while Wegovy’s standard maintenance dose for weight loss is 2.4 mg. Clinical trials for weight loss used the higher Wegovy dose, so using Ozempic at its maximum means you’re getting a somewhat lower dose than what was studied for that purpose.
Compounded Semaglutide as an Alternative
Compounding pharmacies have offered semaglutide at significantly lower prices, sometimes starting around $249 per month or less with bulk purchasing options. These compounded versions contain the same active molecule but are mixed by specialty pharmacies rather than manufactured by Novo Nordisk. The availability of compounded semaglutide has fluctuated based on FDA shortage designations, so this option may not always be accessible. Compounded drugs also don’t go through the same approval process as brand-name medications, which means less regulatory oversight of the final product.
Practical Cost Breakdown
- Ozempic with insurance (for diabetes): $25 to $100 per month with a savings card, potentially higher depending on your plan’s copay structure
- Ozempic without insurance: $900 to $1,000 per month
- Wegovy with insurance (for weight loss): $25 to $100 per month with a savings card, if your plan covers it
- Wegovy without insurance: $1,300 to $1,400 per month
- Compounded semaglutide: roughly $225 to $249 per month, when available
If you’re comparing the two drugs purely on list price, Ozempic saves you about $400 per month. But the real financial question is whether your specific insurance plan covers either drug for your specific diagnosis. A covered Wegovy prescription with a $25 copay is far cheaper than an uncovered Ozempic prescription at $936. Start by checking your plan’s formulary and any prior authorization requirements before assuming one option costs less than the other.